Association between vitamin D deficiency and exercise capacity in patients with CKD, a cross-sectional analysis

Background: Evidence is growing for a role of vitamin D in regulating skeletal muscle mass, strength and functional capacity. Given the role the kidneys play in activating total vitamin D, and the high prevalence of vitamin D deficiency in Chronic Kidney Disease (CKD), it is possible that deficiency contributes to the low levels of physical function and muscle mass in these patients. Methods: This is a secondary cross-sectional analysis of previously published interventional study, with in vitro follow up work. 34 CKD patients at stages G3b-5 (eGFR 25.5 +/- 8.3 mL/min/1.73m2; age 61 +/- 12 years) were recruited, with a sub-group (n = 20) also donating a muscle biopsy. Vitamin D and associated metabolites were analysed in plasma by liquid chromatography tandem-mass spectroscopy and correlated to a range of physiological tests of muscle size, function, exercise capacity and body composition. The effects of 1 alpha,25(OH)2D3 supplementation on myogenesis and myotube size was investigated in primary skeletal muscle cells from vitamin D deficient donors. Results: In vivo, there was no association between total or active vitamin D and muscle size or strength, but a significant correlation with VO2Peak was seen with total vitamin D (25OHD). in vitro, 1 alpha,25(OH)2D3 supplementation reduced IL-6 mRNA expression, but had no effect upon proliferation, differentiation or myotube diameter. Conclusions: Vitamin D deficiency is not a prominent factor driving the loss of muscle mass in CKD, but may play a role in reduced exercise capacity.

Automated summary

The study found that vitamin D deficiency is not a prominent factor driving the loss of muscle mass in CKD patients, but may play a role in reduced exercise capacity.